Entero Therapeutics, Inc. designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. The company's Aggregation Management Platform leverages IoT, AI/ML, and edge analytics to forecast, optimize, and dispatch flexible demand. The company also engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases. It serves residential and small business, commercial and utility, technology and innovation, and hyperscale industries. The company is based in Edinburgh, United Kingdom with additional offices in Prague, Czechia; and Mississauga, Canada.
Frequently asked questions
What sector does Entero Therapeutics, Inc. (ENTO) operate in?
Entero Therapeutics, Inc. belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Entero Therapeutics, Inc. (ENTO) current stock price?
As of the latest data, Entero Therapeutics, Inc. stock price is $2.85, with a previous close of $2.85.
What is Entero Therapeutics, Inc. (ENTO) current market capitalization?
Entero Therapeutics, Inc. market cap is approximately 9.58 million.
What is Entero Therapeutics, Inc. (ENTO) Earnings Per Share (EPS)?
The trailing EPS is -$11.66, and the forward EPS is -$1.52.
Does Entero Therapeutics, Inc. (ENTO) pay dividends?
No. Entero Therapeutics, Inc. does not pay a dividend.
What is Entero Therapeutics, Inc. (ENTO) beta (volatility) score?
Entero Therapeutics, Inc. has a beta of 1.145, meaning its volatility is roughly in line with the market.